YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
The Food and Drug Administration gave the green light to a gene therapy for a rare genetic bleeding disorder created by Pfizer.
Marketed as Beqvez, the drug is for adults with moderate to severe hemophilia B.
The drug has a $3.5 million price tag before insurance and rebates.
Read more from CNBC.
Property enhancements include additional parking and luxury suites tower.